Release Date: 03/07/12 18:43 Summary: Change in Company Secretary and Registered Office Price Sensitive: No Download Document 266.74KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%